ArticleMolecular oncology2016

Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.

Simona Cignetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.